8-K: Chemed's VITAS Healthcare Finalizes $85 Million Acquisition of Covenant Hospice Operations

Chemed Corporation's subsidiary, VITAS Healthcare, has completed the acquisition of hospice operations and an assisted living facility from Covenant Health for $85 million.

Summary

• Chemed Corporation, through its subsidiary VITAS Healthcare, has finalized the acquisition of substantially all hospice operations and an assisted living facility from Covenant Health and Community Services for $85 million.
• The acquired assets include hospice services in several markets across the Florida panhandle and Alabama, specifically Pensacola, Tallahassee, Marianna, Fort Walton Beach, Crestview, and Panama City in Florida, and Dothan and Mobile in Alabama.
• The transaction was funded using cash on hand and was structured as an asset purchase.
• The acquisition was initially announced on March 13, 2024, and closed on April 17, 2024.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the successful completion of a previously announced acquisition, which is a strategic move for the company. The use of cash on hand is also a positive sign. However, the standard forward-looking statement disclaimer introduces a note of caution.

Positives

• The acquisition expands VITAS Healthcare's market presence in Florida and Alabama.
• The purchase was funded with existing cash, avoiding the need for debt or equity financing.
• The transaction was completed as planned, following the initial announcement on March 13, 2024.

Risks

• The press release includes a standard disclaimer about forward-looking statements, cautioning that actual results may differ materially from expectations.
• There is a risk that the integration of the acquired assets may not proceed as smoothly as anticipated.

Future Outlook

The press release includes a standard forward-looking statement disclaimer, cautioning that actual results may differ from expectations and that Chemed does not assume any obligation to update these statements.

Management Comments

• VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation, announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care for an aggregate purchase price of $85 million.

Industry Context

This acquisition is consistent with the trend of consolidation in the healthcare industry, particularly in the hospice care sector, where larger providers seek to expand their geographic reach and market share.

Comparison to Industry Standards

• The acquisition of Covenant's hospice operations by VITAS is a typical move for large hospice providers looking to expand their service areas.
• Other large hospice providers such as Amedisys and LHC Group have also pursued acquisitions to grow their market presence.
• The $85 million price tag is within the range of similar acquisitions in the healthcare sector, though specific multiples would require more detailed financial information.

Stakeholder Impact

• Shareholders may view the acquisition positively as it expands the company's market reach.
• Employees of the acquired Covenant operations will likely transition to VITAS Healthcare.
• Patients in the affected regions will continue to receive hospice care under the VITAS brand.

Key Dates

Keywords

acquisition, hospice, VITAS Healthcare, Chemed Corporation, healthcare, asset purchase, Covenant Health, assisted living